Trial intelligence / Profile preview

Dermagraft long-term follow-up in venous leg ulcers

2010-019887-35Phase 3Completed

Sponsor
Advanced BioHealing
Start
Jun 2010
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 3, open-label trial of Foreskin fibroblast (neonatal) in stasis ulcer (2 cohorts), sponsored by Advanced BioHealing. Primary endpoint: Incidence of study ulcer recurrence. Started Jun 2010; status: completed.

02

Drugs

Foreskin fibroblast (neonatal)
03

Conditions

stasis ulcer

Beyond the preview

Go deeper on 2010-019887-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019887-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call